| top
From the Genome to
the
Proteome
The Next Step:
Functional
Genomics
Human Genome
Project FAQ
ข้อสงสัยที่ถามกันบ่อย
Benefits and
Implications of
Genome
Research
What's a genome?
Why is it important?
Stem Cells: A Primer
ความรู้เบื้องต้นเกี่ยวกับเซลแม่
แบบ
ต้นกำเนิดร่างกายมนุษย์
เซลต้นกำเนิด
ข้อมูลเพิ่มเติมเกี่ยวกับเซลต้น
กำเนิดหรือเซลแม่แบบ
Stem
Cells: A Primer
โครโมโซม
Chromosomes
ออโตโซม
autosomes
โครโมโซมเพศ
Sex chromosomes
การโคลนตัวอ่อนมนุษย์เพื่อ
การศึกษารูปแบบการนำเอา
เซลต้นแบบมาใช้ในการรักษา
ทางการแพทย์
Using cloned human
embryos
for research
Lysosomal Storage
Disorders (LSD)
ความผิดปรกติโครโมโซม
คู่ที่ 5
Cri du chat syndrome



สนใจรายละเอียดเพิ่มเติม
กรุณาแจ้งให้ทึมงานเพื่อ
จัดเตรียมหาสาระให้

Contact :
info@thailabonline.com
ชมรมเรารักสุขภาพ
ไทยแล็ปออนไลน์
|
|
| From the Genome to the
Proteome |
From the Genome to the
Proteome
| Cells are the fundamental working units of every living
system. All the instructions needed to direct their activities are
contained within the chemical DNA (deoxyribonucleic acid).
The genome is an organism's complete set of DNA.
Genomes vary widely in size: the smallest known genome for a free-living
organism (a bacterium) contains about 600,000 DNA base pairs, while
human and mouse genomes have some 3 billion. Except for mature red blood
cells, all human cells contain a complete genome. DNA from all organisms
is made up of the same chemical and physical components. The DNA
sequence is the particular side-by-side arrangement of bases along the
DNA strand (e.g., ATTCCGGA). This order spells out the exact
instructions required to create a particular organism with its own
unique traits.
|
 |
In humans, as in other higher organisms, a DNA molecule consists of
two strands that wrap around each other to resemble a twisted ladder
whose sides, made of sugar and phosphate molecules, are connected by
rungs of nitrogen-containing chemicals called bases. Each strand is a
linear arrangement of repeating similar units called nucleotides,
which are each composed of one sugar, one phosphate, and a nitrogenous
base. Four different bases are present in DNA: adenine (A), thymine (T),
cytosine (C), and guanine (G). The particular order of the bases
arranged along the sugar-phosphate backbone is called the DNA sequence;
the sequence specifies the exact genetic instructions required to create
a particular organism with its own unique traits.
The two DNA strands are held together by weak bonds between the bases
on each strand, forming base pairs (bp). Genome size is usually
stated as the total number of base pairs; the human genome contains
roughly 3 billion bp.
If unwound and tied together, the strands of human DNA would stretch
more than 5 feet but would be only 50 trillionths of an inch wide. For
each organism, the components of these slender threads encode all the
information necessary for building and maintaining life, from simple
bacteria to remarkably complex human beings. Understanding how DNA
performs this function requires some knowledge of its structure and
organization.
 |
Each time a cell divides into two daughter cells, its full genome is
duplicated; for humans and other complex organisms, this duplication
occurs in the nucleus. During cell division the DNA molecule
unwinds and the weak bonds between the base pairs break, allowing the
strands to separate. Each strand directs the synthesis of a
complementary new strand, with free nucleotides matching up with their
complementary bases on each of the separated strands. Strict
base-pairing rules are adhered to; adenine will pair only with thymine
(an A-T pair) and cytosine with guanine (a C-G pair). Each daughter cell
receives one old and one new DNA strand. The cells' adherence to these
base-pairing rules ensures that the new strand is an exact copy of the
old one. This minimizes the incidence of errors (mutations) that may
greatly affect the resulting organism or its offspring. |
| DNA in the human genome is arranged into 24 distinct chromosomes--physically
separate molecules that range in length from about 50 million to 250
million base pairs. All genes are arranged linearly along the
chromosomes. The nucleus of most human cells contains two sets of
chromosomes, one set given by each parent. Each set has 23 single
chromosomes--22 autosomes and an X or Y sex chromosome. (A normal female
will have a pair of X chromosomes; a male will have an X and Y pair.)
Chromosomes contain roughly equal parts of protein and DNA; chromosomal
DNA contains an average of 150 million bases. DNA molecules are among
the largest molecules now known.
Chromosomes can be seen under a light microscope and, when stained
with certain dyes, reveal a pattern of light and dark bands reflecting
regional variations in the amounts of A and T vs G and C. Differences in
size and banding pattern allow the 24 chromosomes to be distinguished
from each other, an analysis called a karyotype. A few types of major
chromosomal abnormalities, including missing or extra copies or gross
breaks and rejoinings (translocations), can be detected by microscopic
examination; Down's syndrome, in which an individual's cells contain a
third copy of chromosome 21, is diagnosed by karyotype analysis.
Most changes in DNA, however, are too subtle to be detected by this
technique and require molecular analysis. These subtle DNA abnormalities
(mutations) are responsible for many inherited diseases such as cystic
fibrosis and sickle cell anemia or may predispose an individual to
cancer, major psychiatric illnesses, and other complex diseases.
|
 |
Each chromosome contains many genes, the basic physical and
functional units of heredity. Genes are specific sequences of bases that
encode instructions on how to make proteins, the molecules that perform
most life functions and even make up the majority of cellular
structures. Genes comprise only about 2% of the human genome; the
remainder consists of noncoding regions, whose functions may include
providing chromosomal structural integrity and regulating where, when,
and in what quantity proteins are made. The human genome is estimated to
contain 30,000 to 40,000 genes.
Human genes vary widely in length, often extending over thousands of
bases, but only about 10% of the genome is known to include the
protein-coding sequences (exons) of genes. Interspersed with many genes
are intron sequences, which have no coding function. The balance of the
genome is thought to consist of other noncoding regions (such as control
sequences and intergenic regions), whose functions are obscure.
 |
Although genes get a lot of attention, it's the proteins that
perform most life functions. Proteins are large, complex molecules made
up of smaller subunits called amino acids. Twenty different kinds of
amino acids are usually found in proteins. Within the gene, each
specific sequence of three DNA bases (codons) directs the cells'
protein-synthesizing machinery to add specific amino acids. For example,
the base sequence ATG codes for the amino acid methionine. Since 3 bases
code for 1 amino acid, the protein coded by an average-sized gene (3000
bp) will contain 1000 amino acids. The genetic code is thus a series of
codons that specify which amino acids are required to make up specific
proteins. Chemical properties that distinguish the 20 different amino
acids cause the protein chains to fold up into specific
three-dimensional structures that define their particular functions in
the cell. |
| The constellation of all proteins in a cell is called its proteome.
Unlike the relatively unchanging genome, the dynamic proteome changes
from moment to moment in response to tens of thousands of intra- and
extracellular environmental signals. A protein's chemistry and behavior
is specified by the gene sequence and by the number and identities of
other proteins made in the same cell at the same time and with which it
associates and reacts. Studies to explore protein structure and their
activities, known as proteomics, will be the focus of much research for
decades to come and will help elucidate the molecular basis of health
and disease.
The protein-coding instructions from the genes are transmitted
indirectly through messenger ribonucleic acid (mRNA), a transient
intermediary molecule similar to a single strand of DNA. For the
information within a gene to be expressed, a complementary RNA strand is
produced (a process called transcription) from the DNA template
in the nucleus. This mRNA is moved from the nucleus to the cellular
cytoplasm, where it serves as the template for protein synthesis. The
cells' protein-synthesizing machinery then translates the codons into a
string of amino acids that will constitute the protein molecule for
which it codes. In the laboratory, the mRNA molecule can be isolated and
used as a template to synthesize a complementary DNA (cDNA) strand,
which can then be used to locate the corresponding genes on a chromosome
map.
|
 |
What We've Learned So
Far...Achievement of a Draft Sequence
In June of 2000, HGP leaders, Craig Venter of the private company
Celera Genomics, and President Clinton announced the completion of a
"working draft" DNA sequence of the human genome.
In February 2001, HGP and Celera Genomics scientists published the
long-awaited details of the working-draft DNA sequence achieved less
than a year before. Although the draft is filled with mysteries, the
first panoramic view of the human genetic landscape has revealed a
wealth of information and some early surprises. Papers describing
research observations in the journals Nature (Feb. 15, 2001) and Science
(Feb. 16, 2001) are freely accessible via the Web.
Although clearly not a Holy Grail or Rosetta Stone for deciphering
all of biology two early metaphors commonly used to describe the coveted
prize the sequence is a magnificent and unprecedented resource that will
serve as a basis for research and discovery throughout this century and
beyond. It will have diverse practical applications and a profound
impact upon how we view ourselves and our place in the tapestry of life
around us.
One insight already gleaned from the sequence is that, even on the
molecular level, we are more than the sum of our 35,000 or so genes.
Surprisingly, this newly estimated number of genes is only one-third as
great as previously thought and is only twice as many as those of a tiny
transparent worm, although the numbers may be revised as more
computational and experimental analyses are performed. At once humbled
and intrigued by this finding, scientists suggest that the genetic key
to human complexity lies not in the number of genes but in how gene
parts are used to build different products in a process called
alternative splicing. Other sources of added complexity are the
thousands of post-translational chemical modifications made to proteins
and the repertoire of regulatory mechanisms controlling these processes.
The draft encompasses 90% of the human genome's euchromatic portion,
which contains the most genes. In constructing the working draft, the 16
genome sequencing centers produced over 22.1 billion bases of raw
sequence data, comprising overlapping fragments totaling 3.9 billion
bases and providing sevenfold coverage (sequenced seven times) of the
human genome. Over 30% is high-quality, finished sequence, with eight-
to tenfold coverage, 99.99% accuracy, and few gaps. All data are freely
available via the Web.
The entire working draft will be finished to high quality by 2003.
Coincidentally, that year also will be the 50th anniversary of Watson
and Crick's publication of DNA structure that launched the era of
molecular genetics (www.nature.com/genomics/human/watson-crick). Much
will remain to be deciphered even then. Some highlights
from Nature, Science, and The Wellcome Trust follow.
What Does the Draft Human Genome Sequence Tell Us?
By the Numbers
- The human genome contains 3164.7 million chemical nucleotide bases
(A, C, T, and G).
- The average gene consists of 3000 bases, but sizes vary greatly,
with the largest known human gene being dystrophin at 2.4 million bases.
- The total number of genes is estimated at 30,000 to 35,000 much
lower than previous estimates of 80,000 to 140,000 that had been based
on extrapolations from gene-rich areas as opposed to a composite of
gene-rich and gene-poor areas.
- Almost all (99.9%) nucleotide bases are exactly the same in all
people.
- The functions are unknown for over 50% of discovered genes.
The Wheat from the Chaff
- Less than 2% of the genome codes for proteins.
- Repeated sequences that do not code for proteins ("junk
DNA") make up at least 50% of the human genome.
- Repetitive sequences are thought to have no direct functions, but
they shed light on chromosome structure and dynamics. Over time, these
repeats reshape the genome by rearranging it, creating entirely new
genes, and modifying and reshuffling existing genes.
- During the past 50 million years, a dramatic decrease seems to have
occurred in the rate of accumulation of repeats in the human genome.
How It's Arranged
- The human genome's gene-dense "urban centers" are
predominantly composed of the DNA building blocks G and C.
- In contrast, the gene-poor "deserts" are rich in the DNA
building blocks A and T. GC- and AT-rich regions usually can be seen
through a microscope as light and dark bands on chromosomes.
- Genes appear to be concentrated in random areas along the genome,
with vast expanses of noncoding DNA between.
- Stretches of up to 30,000 C and G bases repeating over and over
often occur adjacent to gene-rich areas, forming a barrier between the
genes and the "junk DNA." These CpG islands are believed to
help regulate gene activity.
- Chromosome 1 has the most genes (2968), and the Y chromosome has the
fewest (231).
How the Human Compares with Other Organisms
- Unlike the human's seemingly random distribution of gene-rich areas,
many other organisms' genomes are more uniform, with genes evenly spaced
throughout.
- Humans have on average three times as many kinds of proteins as the
fly or worm because of mRNA transcript "alternative splicing"
and chemical modifications to the proteins. This process can yield
different protein products from the same gene.
- Humans share most of the same protein families with worms, flies,
and plants, but the number of gene family members has expanded in
humans, especially in proteins involved in development and immunity.
- The human genome has a much greater portion (50%) of repeat
sequences than the mustard weed (11%), the worm (7%), and the fly (3%).
- Although humans appear to have stopped accumulating repeated DNA
over 50 million years ago, there seems to be no such decline in rodents.
This may account for some of the fundamental differences between
hominids and rodents, although gene estimates are similar in these
species. Scientists have proposed many theories to explain evolutionary
contrasts between humans and other organisms, including those of life
span, litter sizes, inbreeding, and genetic drift.
Variations and Mutations
- Scientists have identified about 1.4 million locations where
single-base DNA differences (SNPs) occur in humans. This information
promises to revolutionize the processes of finding chromosomal locations
for disease-associated sequences and tracing human history.
- The ratio of germline (sperm or egg cell) mutations is 2:1 in males
vs females. Researchers point to several reasons for the higher mutation
rate in the male germline, including the greater number of cell
divisions required for sperm formation than for eggs.
Applications, Future Challenges
Deriving meaningful knowledge from the DNA sequence will define research
through the coming decades to inform our understanding of biological
systems. This enormous task will require the expertise and creativity of
tens of thousands of scientists from varied disciplines in both the
public and private sectors worldwide.
The draft sequence already is having an impact on finding genes
associated with disease. Over 30 genes have been pinpointed and
associated with breast cancer, muscle disease, deafness, and blindness.
Additionally, finding the DNA sequences underlying such common diseases
as cardiovascular disease, diabetes, arthritis, and cancers is being
aided by the human variation maps (SNPs) generated in the HGP in
cooperation with the private sector. These genes and SNPs provide
focused targets for the development of effective new therapies.
One of the greatest impacts of having the sequence may well be in
enabling an entirely new approach to biological research. In the past,
researchers studied one or a few genes at a time. With whole-genome
sequences and new high-throughput technologies, they can approach
questions systematically and on a grand scale. They can study all the
genes in a genome, for example, or all the transcripts in a particular
tissue or organ or tumor, or how tens of thousands of genes and proteins
work together in interconnected networks to orchestrate the chemistry of
life.
The Next Step: Functional
Genomics
The words of Winston Churchill, spoken in 1942 after 3 years of war,
capture well the HGP era: "Now this is not the end. It is not even
the beginning of the end. But it is, perhaps, the end of the
beginning."
The avalanche of genome data grows daily. The new challenge will be
to use this vast reservoir of data to explore how DNA and proteins work
with each other and the environment to create complex, dynamic living
systems. Systematic studies of function on a grand scale-functional
genomics-will be the focus of biological explorations in this century
and beyond. These explorations will encompass studies in transcriptomics,
proteomics, structural genomics, new experimental methodologies, and
comparative genomics.
- Transcriptomics involves large-scale analysis of messenger
RNAs transcribed from active genes to follow when, where, and under what
conditions genes are expressed.
- Studying protein expression and function--or proteomics--can
bring researchers closer to what's actually happening in the cell than
gene-expression studies. This capability has applications to drug
design.
- Structural genomics initiatives are being launched worldwide
to generate the 3-D structures of one or more proteins from each protein
family, thus offering clues to function and biological targets for drug
design.
- Experimental methods for understanding the function of DNA sequences
and the proteins they encode include knockout studies to
inactivate genes in living organisms and monitor any changes that could
reveal their functions.
- Comparative genomics--analyzing DNA sequence patterns of
humans and well-studied model organisms side-by-side-has become one of
the most powerful strategies for identifying human genes and
interpreting their function.
Select a
Subject
- Human Genome Project --answers to the who, what,
when, why, and how much of the Project
- Benefits and Implications of Genome Research
--information about Project benefits, the ethical, legal, and social
issues associated with the project, gene testing, and medicine
- Genetics --answers to whose genome is being
used, what's a genome, how big is a genome, what is model organism
research, what is cloning, where can I find out about a particular
disease, and other questions
Human Genome Project
Q. What is
the Human Genome Project?
The Human Genome Project (HGP) is an international 13-year effort
formally begun in October 1990. The project was planned to last 15
years, but rapid technological advances have accelerated the expected
completion date to 2003. Project goals
are to discover all the approximate 30,000 to 35,000 human genes (the
human genome) and make them accessible for further biological study and
to determine the complete sequence of the 3 billion DNA subunits
(bases). As part of the HGP, parallel studies are being carried out on
selected model organisms such as the bacterium E. coli to help
develop the technology and interpret human gene function. The Department
of Energy's Human Genome Program and the National Institutes of Health's
National Human Genome Research Institute (NHGRI) together make up the
U.S. Human Genome Project.
A rough
draft of the human genome was completed in June 2000. Efforts are
still underway to complete the finished,
high-quality sequence.
For more information, see About
the Human Genome Project. [01/01]
Q. Who is
head of the U.S. Human Genome Project?
The Department of Energy's Human Genome Program is directed by Ari
Patrinos, head of the Office of Biological and Environmental Research.
Francis Collins directs the National Institutes of Health National Human
Genome Research Institute. [01/01]
Q. How far
along is the project? How many genes have been identified?
In June 2000, scientists completed the first working draft of the
human genome. Efforts are still underway to complete a high-quality,
"finished" sequence. See the Human
Genome Project Progress Web page for an update on all aspects of the
Human Genome Project including sequencing, mapping, BAC End sequencing,
and ethical, legal, and social issues. See also the Human Genome Project
History Web
page.[01/01]
Q. What
are the goals of the Human Genome Project?
See the Human
Genome Project Goals Web page for the latest HGP goals (1998-2003).
[01/01]
Q. What
U.S. laboratories and investigators are involved in the Human Genome
Project?
Many laboratories around the United States receive funding from
either the Department of Energy (DOE) or the National Institutes of
Health (NIH), or both, for Human Genome Project research. A list of the
major U.S. and international Human Genome Project research sites can be
found here.
Other researchers at numerous colleges, universities, and
laboratories throughout the United States also receive DOE and NIH
funding for human genome research. At any given time, the DOE Human
Genome Program funds about 200 separate principal investigators. For
DOE-funded projects, see Research
in Progress. See a list of NIH-funded projects here.
In addition, many private companies are conducting genome research.
For more on this, see the HGP
and the Private Sector Fact Sheet. [01/01]
Q. What
other countries are participating in the HGP?
At least 18 countries have established human genome research
programs. Some of the larger programs are in Australia, Brazil, Canada,
China, Denmark, European Union, France, Germany, Israel, Italy, Japan,
Korea, Mexico, Netherlands, Russia, Sweden, United Kingdom, and the
United States. Some developing countries are participating through
studies of molecular biology techniques for genome research and studies
of organisms that are particularly interesting to their geographical
regions. The Human Genome Organisation (HUGO)
helps to coordinate international collaboration in the genome project.
A list of the major U.S. and international Human Genome Project
research sites can be found here.
[01/01]
Q. What
happens when the genome sequence is completed?
Completing the genome sequence is just the first step. See a list of post-sequencing
research challenges on the Sequencing Fact Sheet. [01/01]
Q. The
Human Genome Project published papers about the working draft sequence
in February 2001. What was learned from this working draft sequence?
See an index
of the papers and a list of insights
learned from this information. [2001]
Q. About
how much have the Department of Energy and the National Institutes of
Health spent on the Human Genome Project since it began in 1988?
See the joint DOE-NIH Budget
of the Human Genome Project. [08/00]
Q. Why is
the Department of Energy (DOE) involved in the Human Genome Project?
See the answer
on the Department of Energy and the HGP Fact Sheet. [01/01]
Q.
What DOE investments have
improved the Human Genome Project by reducing costs, speeding progress,
furthering technology?
See the answer
on the Department of Energy and the HGP Fact Sheet. [01/01]
Q. Where
can I find details about the Department of Energy's Human Genome
Program?
See the answer
on the Department of Energy and the HGP Fact Sheet. [01/01]
return to subject listing
at top of page
Benefits and Implications of Genome
Research
Q. What
are the potential benefits of human genome research?
The project will reap fantastic benefits for humankind, some that we
can anticipate and others that will surprise us. Generations of
biologists and researchers will be provided with detailed DNA
information that will be key to understanding the structure,
organization, and function of DNA in chromosomes. Genome maps of other
organisms will provide the basis for comparative studies that are often
critical to understanding more complex biological systems. Information
generated and technologies developed will revolutionize future
biological explorations.
For details about the applications of human genome project research,
see Potential
Benefits of Human Genome Project Research.
Click here
to see a poster depicting resources gained from Human Genome Project
research. [01/01]
Q. What are
some of the ethical, legal, and social challenges presented by genetic
information, and what is being done to address these issues?
The DOE and NIH genome programs set aside 3% to 5% of their
respective total annual budgets for the study of the project's ethical,
legal, and social issues (ELSI). For an in-depth look at the ELSI
surrounding the project, see Ethical,
Legal, and Social Issues (ELSI) of the Human Genome Project. For
more on ongoing ELSI research, see our ELSI
Research page.[01/01]
Q.
What laws exist to protect us from genetic discrimination in insurance
and in the workplace?
See the answer on our Privacy
and Legislation Web page. [08/00]
Q. What
is gene patenting? Is DNA patentable? What laws govern gene patenting?
See the answer on our Patenting
Web page. [01/01]
Q. What
is gene testing? How does it work?
See the answer on our Gene
Testing Web page. [01/01]
Q.
Does behavior have a biological basis? Are our actions and emotions
related to our genetic makeup?
See the answer on our Behavioral
Genetics Web page. [01/01]
Q.
How can you be identified by your DNA? What are other applications for
DNA forensics? If we are 99% alike, won't two people likely have the
same DNA makeup?
See the answer on our DNA
Forensics page. [01/01]
Q. How
will the Human Genome Project impact medicine?
See the answer on our Medicine
and the New Genetics Web page. [08/00]
Q. Where
can I find easy-to-understand information about a specific genetic
disease?
See the answer on the Genetic
Disease Information Web page.[01/01]
Q. Is
gene therapy being used to cure diseases? What is its promise for the
future of medicine?
See the answer on our Gene
Therapy Web page. [01/01]
Q. What
is pharmacogenomics? How will it change my trips to the doctor's office?
See the answer on our Pharmacogenomics
Web page. [01/01]
Q.
What do genetic counselors do? Why would I need one? How can I become
one?
See the answer on our Genetic
Counseling Web page. [01/01]
return to subject listing
at top of page
Genetics
Q.
What's a genome? And why is it important?
A genome is all the DNA in an organism, including its genes. Genes
carry information for making all the proteins required by all organisms.
These proteins determine, among other things, how the organism looks,
how well its body metabolizes food or fights infection, and sometimes
even how it behaves.
DNA is made up of four similar chemicals (called bases and
abbreviated A, T, C, and G) that are repeated millions or billions of
times throughout a genome. The human genome, for example, has 3 billion
pairs of bases.
The particular order of As, Ts, Cs, and Gs is extremely important.
The order underlies all of life's diversity, even dictating whether an
organism is human or another species such as yeast, rice, or fruit fly,
all of which have their own genomes and are themselves the focus of
genome projects. Because all organisms are related through similarities
in DNA sequences, insights gained from nonhuman genomes often lead to
new knowledge about human biology. [01/01]
Q. How
big is the human genome?
The human genome is made up of DNA, which has four different chemical
building blocks. These are called bases and abbreviated A, T, C, and G.
In the human genome, about 3 billion bases are arranged along the
chromosomes in a particular order for each unique individual. To get an
idea of the size of the human genome present in each of our cells,
consider the following analogy: If the DNA sequence of the human genome
were compiled in books, the equivalent of 200 volumes the size of a
Manhattan telephone book (at 1000 pages each) would be needed to hold it
all.
It would take about 9.5 years to read out loud (without stopping) the
3 billion bases in a person's genome sequence. This is calculated on a
reading rate of 10 bases per second, equaling 600 bases/minute, 36,000
bases/hour, 864,000 bases/day, 315,360,000 bases/year.
Storing all this information is a great challenge to computer experts
known as bioinformatics specialists. One million bases (called a
megabase and abbreviated Mb) of DNA sequence data is roughly equivalent
to 1 megabyte of computer data storage space. Since the human genome is
3 billion base pairs long, 3 gigabytes of computer data storage space
are needed to store the entire genome. This includes nucleotide sequence
data only and does not include data annotations and other information
that can be associated with sequence data.
As time goes on, more annotations will be entered as a result of
laboratory findings, literature searches, data analyses, personal
communications, automated data-analysis programs, and auto annotators.
These annotations associated with the sequence data will likely dwarf
the amount of storage space actually taken up by the initial 3 billion
nucleotide sequence. Of course, that's not much of a surprise because
the sequence is merely one starting point for much deeper biological
understanding!
Contributions to this answer were made by Morey Parang and Richard
Mural formerly of Oak Ridge National Laboratory; and Mark Adams formerly
of The Institute of Genome Research. [01/01]
Q. Whose
genome is being sequenced in the public (HGP) and private projects?
See answer on the Facts About Genome Sequencing page.
[01/01]
Q.
Where can I find maps of genes that have been found on different
chromosomes?
See the online poster, Human
Genome Landmarks: Selected Traits and Disorders Mapped to Chromosomes.
This poster provides chromosome-by-chromosome maps of some of the genes
that have been mapped to each chromosomes. These maps were generated
using the Online Mendelian
Inheritance in Man database.
Another good place to get maps is by accessing the Genome
Database (GDB), which is the worldwide repository of human genome
mapping data. A feature allows users to list genes by chromosome and to
print maps (requires PostScript). Go to the main report page.
In conjunction with the October 1998 special genome issue of Science,
NCBI released an updated online map
of more than 30,000 genes. An older map from the 1996 special genome
issue of Science
is also available. [01/01]
Q.
What is DNA sequencing, and how is it done?
See the answer on the Facts About Genome Sequencing page.
[01/01]
Q. Why
is model organism research important? How closely related are mice and
humans? Why do we care what diseases mice get?
See the answer
on the Functional and Comparative Genomics Fact Sheet. [01/01]
Q.
What genomes have been sequenced completely?
See the answer
on the Functional and Comparative Genomics Fact Sheet. [01/01]
Q.
When is a genome completely sequenced?
See the answer on the Facts About Genome Sequencing page.
[01/01]
Q.
What are the comparative genome sizes of humans and other organisms
being studied?
See the answer
on the Functional and Comparative Genomics Fact Sheet. [01/01]
Q.
What is jumping DNA?
Nearly half of the human genome is composed of transposable elements
or jumping DNA. First recognized in the 1940s by Dr. Barbara McClintock
in studies of peculiar inheritance patterns found in the colors of
Indian corn, jumping
DNA refers to the idea that some stretches of DNA are unstable and
"transposable," ie., they can move aroundon and between
chromosomes.
This theory was confirmed in the 1980s when scientists observed
jumping DNA in other genomes. Now scientists believe transposons may be
linked to some genetic disorders such as hemophilia, leukemia, and
breast cancer. They also believe that transposons may have played
critical roles in human evolution.
McClintock received a Nobel prize in 1983 for her discoverymaking
her one of only two women ever to receive an unshared Nobel prize in
science. The other was Marie Curie.
To learn more about McClintock and her research, see
Q.
What is cloning?
See the answer
on the Cloning fact sheet Web page. [01/01]
This Web site is being continuously updated, and
HGMIS appreciates your input. Please send updates, questions, or
comments to caseydk@ornl.gov
and URL updates or Web questions to martinsa@ornl.gov.
|
Last modified: Monday, May 14, 2001

|